A 24-year collaboration transforms health care in Tanzania

Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.

Do starchy carbs cause cavities?

New research provides evidence that – depending on your genetic makeup and oral microbiome – starch could contribute to cavities and gum disease.

Altier, Parrish elected to microbiology academy

Dr. Craig Altier and Colin Parrish, Ph.D. ’84, both of the College of Veterinary Medicine, have been elected to the American Academy of Microbiology, the honorific leadership group within the American Society for Microbiology.

Designing self-destructing bacteria to make effective TB vaccines

Working toward more effective tuberculosis vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered to stop the bacteria after they activate an immune response.

Ethical Depth: The cure for today’s medical industry

New Cornell Johnson School research explores why doctors may fall prey to conflicts of interest and proposes a new approach called “deep professionalism.”

Around Cornell

Roundtable to consider ‘Science Under Siege’

The Feb. 28  event will provide a forum for scientists, social scientists and humanities scholars to discuss challenges to research support in response to recent major changes to federal funding.

Backyard poultry at risk when migrating mallards stop to rest

Knowing the duration and timing of when migrating mallard ducks – natural carriers of avian influenza – stop and rest can help predict the probability that they will infect backyard poultry flocks.

Islet-transplantation procedure shows promises against T1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

New therapy may effectively control HIV in Uganda

A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.